AIMZ Investment Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Sell |
61,867
-392
| -0.6% | -$15.1K | 0.8% | 41 |
|
|
2025
Q1 | $2.41M | Sell |
62,259
-272
| -0.4% | -$10.5K | 0.84% | 41 |
|
|
2024
Q4 | $2.11M | Buy |
62,531
+666
| +1% | +$22.5K | 0.73% | 43 |
|
|
2024
Q3 | $2.53M | Sell |
61,865
-474
| -0.8% | -$19.4K | 0.86% | 35 |
|
|
2024
Q2 | $2.4M | Sell |
62,339
-593
| -0.9% | -$22.8K | 0.86% | 36 |
|
|
2024
Q1 | $2.7M | Sell |
62,932
-1,195
| -2% | -$51.2K | 1.01% | 35 |
|
|
2023
Q4 | $2.38M | Sell |
64,127
-554
| -0.9% | -$20.5K | 0.96% | 36 |
|
|
2023
Q3 | $2.34M | Sell |
64,681
-734
| -1% | -$26.6K | 1.04% | 34 |
|
|
2023
Q2 | $2.33M | Buy |
65,415
+6
| +0% | +$214 | 1% | 36 |
|
|
2023
Q1 | $2.33M | Sell |
65,409
-542
| -0.8% | -$19.3K | 1.04% | 37 |
|
|
2022
Q4 | $2.32M | Sell |
65,951
-7,113
| -10% | -$250K | 1.09% | 36 |
|
|
2022
Q3 | $2.15M | Buy |
+73,064
| New | +$2.15M | 1.09% | 36 |
|
|
2022
Q2 | – | Sell |
-74,426
| Closed | -$4.05M | – | 112 |
|
|
2022
Q1 | $4.05M | Sell |
74,426
-3,021
| -4% | -$164K | 1.67% | 17 |
|
|
2021
Q4 | $4.27M | Buy |
77,447
+1,848
| +2% | +$102K | 1.66% | 15 |
|
|
2021
Q3 | $3.61M | Buy |
75,599
+1,367
| +2% | +$65.3K | 1.63% | 16 |
|
|
2021
Q2 | $3.7M | Buy |
74,232
+490
| +0.7% | +$24.4K | 1.66% | 16 |
|
|
2021
Q1 | $3.29M | Buy |
73,742
+54
| +0.1% | +$2.41K | 1.61% | 19 |
|
|
2020
Q4 | $3.39M | Sell |
73,688
-400
| -0.5% | -$18.4K | 1.78% | 17 |
|
|
2020
Q3 | $3.49M | Buy |
+74,088
| New | +$3.49M | 2.09% | 13 |
|